Resources

Patients taking a novel diet drug that combines the stimulant phentermine with the anticonvulsant, topiramate lost an average of 37 pounds over a year with significant improvement in a number of cardiovascular risk factors.

We reviewed this information just a couple of weeks ago, but it is important enough to take another look at the results.

Men and women with smaller thighs have an increased risk for heart disease and early death compared with those with larger thighs, according to results of a large cohort study.

An international consortium of scientists has identified a new genetic variant associated with Type 2 diabetes, insulin resistance, and hyperinsulinemia , Dr. Johan Rung Cambridge, UK, and colleagues report.

An elevated fasting glucose level at hospital admission among patients with acute coronary syndrome (ACS) is associated with increased risk of death and other cardiovascular events up to 6 months later, U.S. researchers report.

The widespread recommendation for the routine use of low-dose aspirin in primary prevention of cardiovascular events for all patients with Type 2 diabetes should be revisited, experts said at theEuropean Society of Cardiology 2009 Congress.

There are common genetic factors that slightly predispose individuals to develop both periodontal disease and cardiovascular disease, a prospective study of Swedish twins indicates.

Exsulin Corporation announces next hase II trial of novel islet regeneration treatment in Type 1 diabetes. Leading diabetes research centers collaborate on new trial designed to further evaluate regeneration treatment for people with Type 1 diabetes.

New research indicates that patients with lesser degrees of celiac disease-related symptoms, such as intestinal inflammation or latent celiac disease, have a modestly increased risk of death, according to a study.

Expression of the tumor suppressor gene p53 in adipose tissue plays a key role in the development of insulin resistance, new studies in mice and humans reveal.